Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

The rise of antibiotic resistance and a dwindling antimicrobial pipeline have been
recognized as emerging threats to public health. The ESKAPE pathogens—Enterococcus …

Acinetobacter baumannii-calcoaceticus complex is the most commonly identified species in
the genus Acinetobacter and it accounts for a large percentage of nosocomial infections …

The role of food‐producing environments in the emergence and spread of antimicrobial
resistance (AMR) in EU plant‐based food production, terrestrial animals (poultry, cattle and …

Acinetobacter baumannii is a common cause of healthcare-associated infections and
hospital outbreaks, particularly in intensive care units. Much of the success of A. baumannii …

Introduction Non-baumannii Acinetobacter species are increasingly isolated in the clinical
setting and the environment. The aim of the present study was to analyze a genome …

Background Acinetobacter baumannii has emerged as one of the common multidrug
resistance pathogens causing hospital-acquired infections. This study was conducted to …

Acinetobacter baumannii is a Gram-negative coccobacillus with exceptional survival skills in
an unfavorable environment and the ability to rapidly acquire antibiotic resistance, making it …

Healthcare-associated carbapenem-resistant Acinetobacter baumannii (CRAB) infections
are a serious threat associated with global epidemic clones and a variety of carbapenemase …

At the Bundeswehr Hospitals of Hamburg and Westerstede, patients repatriated from
subtropical war and crisis zones of Northern Africa and the Middle East were medically …